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Early Intravenous Infusion of Sodium Nitrite Protects Brain
Against In Vivo Ischemia-Reperfusion Injury
Keun-Hwa Jung, MD; Kon Chu, MD; Song-Yi Ko, MS; Soon-Tae Lee, MD;
Dong-In Sinn, MD; Dong-Kyu Park, BS; Jeong-Min Kim, MD; Eun-Cheol Song, MD;
Manho Kim, MD, PhD; Jae-Kyu Roh, MD, PhD
Background and Purpose—The rate of nitric oxide (NO) generation from nitrite is linearly dependent on reductions in
oxygen and pH levels. Recently, nitrite-derived NO has been reported to exert a profound protection against liver and
heart ischemia-reperfusion injury. In this study, we hypothesized that nitrite would be reduced to NO in the ischemic
brain and exert NO-dependent neuroprotective effects.
Methods—Cerebral ischemia-reperfusion injury was induced by intraluminal thread occlusion of middle cerebral artery in
the adult male rats. Solutions of sodium nitrite were infused intravenously at the time of reperfusion. Sodium nitrate and
carboxy-PTIO (30 minutes before ischemic surgery), a direct NO scavenger, were infused for comparisons.
Results—Nitrite reduced infarction volume and enhanced local cerebral blood flow and functional recovery. The effects
were observed at concentrations of 48 nmol and 480 nmol, but not at 4800 nmol nitrite and 480 nmol nitrate. The
neuroprotective effects of nitrite were inhibited completely by the carboxy-PTIO. The 480 nmol nitrite attenuated
dihydroethidium activity, 3-nitrotyrosine formation, and lipid peroxidation in the ischemic brain.
Conclusions—Nitrite exerted profound neuroprotective effects with antioxidant properties in the ischemic brains. These
results suggest that nitrite, as a biological storage reserve of NO, may be a novel therapeutic agent in the setting of acute
stroke. (Stroke. 2006;37:2744-2750.)
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Recent insight into the basic mechanism involved in ische-mic stroke indicates that endothelial dysfunctions along
with the oxidative stress and inflammation represent a key step
in the cerebral ischemia/reperfusion (I/R) injury.1 Nitric oxide
(NO) is primarily known for an endothelial survival factor
maintaining the endothelial integrity and a vasodilator regulating
the blood flow.2 In addition to its major role, as a potentially
protective agent, NO can improve neuronal survival, inhibit
platelet aggregation and neutrophil adhesion, and scavenge
reactive free radicals, thus reducing the ischemic injury.3,4
However, a concomitant surge in production of superoxide and
NO after reperfusion may lead to formation of peroxynitrite, a
powerful oxidant.5 So far, evidences have indicated that NO may
be linked both to protective and toxic effects after I/R, depending
on the level, the location, the source, and the environment.6–8
NO synthase (NOS) is a dominant physiological source of
NO. However, the enzymatic activity of NOS requires oxy-
gen and is blocked under hypoxia. Therefore, alternative
pathways for hypoxic release of NO have high physiological
relevance. The agents that liberate NO have been recognized
as highly critical for therapeutic purposes especially in ischemic
disorders. A variety of structurally different NO donors have
been shown to limit infarct size by improving blood flow in the
penumbra areas and reducing the oxidative stress in an NO-
dependent fashion.9–11 Recent works support the application of
nitrite as a direct NO donor for treatment of ischemic disorders.
The anion nitrite is reduced to form NO as a result of reduction
by deoxyhemoglobin, myoglobin, tissue heme proteins, and
nonenzymatic disproportionating.12,13 The NO release from ni-
trite, and in parallel the vasodilatory effect, are increased under
conditions of acidosis, hypoxia, and tissue I/R.14 This improved
understanding of the biochemical conversion of nitrite to NO has
resulted in a great deal of interest in the potential beneficial
effects of nitrite therapy in animal models of ischemia.13
The ischemic cerebral environment might allow for the
acidic and hypoxic reduction of nitrite to NO. In this study,
we investigated whether hypoxia-dependent NO production
from nitrite in ischemic brain might limit I/R injury.
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Materials and Methods
Focal Transient Cerebral I/R
All the procedures were performed following an institutional ap-
proval in accordance with NIH Guide for the Care and Use of
Laboratory Animals. Male Sprague-Dawley rats (12 weeks old;
Genomics, Republic of Korea), weighing 200 to 220 grams, were
randomly assigned to 3 experimental groups: drug-treated I/R group
(n87); saline-treated I/R group (n30); and normal control group
(n9). Focal cerebral ischemia was induced by performing intralu-
minal filamentous occlusion of the middle cerebral artery for 90
minutes, according to methods that have been described.15 After 90
minutes of middle cerebral artery (MCA) occlusion, the reperfusion
of the MCA was initiated by removing the MCA occlusive filament.
The right femoral artery was cannulated to monitor mean arterial
blood pressure, arterial blood gases, and pH.
Experimental Protocols
The drug-treated rats were randomly assigned to nitrite-treated,
nitrate-treated, and carboxy-PTIO-nitrite groups. Sodium nitrite and
sodium nitrate (Sigma-Aldrich) were dissolved in phosphate-
buffered saline and the pH was adjusted to 7.4. In all experiments, a
final volume of 500 L containing sodium nitrite (48 to 4800
nanomoles) or sodium nitrate (480 nmol) was administered intrave-
nously to the rats for 1 minute via intravenous cannula situated in the
tail vein at the time of reperfusion. Carboxy-PTIO [2-(4-
carboxyphenyl)-4, 4, 5, 5-tetramethylimidazoline-1-oxyl-3-oxide po-
tassium salt], a direct intravascular NO scavenger, was used to
inhibit NO-dependent effects. Carboxy-PTIO (Alexis Biochemicals)
was dissolved in phosphate-buffered saline and was administered
intravenously at a dose of 1 mg/kg in a volume of 500 L, 30 minutes
before ischemia.
Evaluation of Infarct Volume
We measured infarction volumes (at 1 day after I/R, n12 per
group) using 2,3,5-triphenyltetrazolium chloride (TTC; Sigma)
staining, as described elsewhere.15 The infarcted and total hemi-
spheric areas of each section, at intervals of 1-mm thickness, were
traced and measured using an image analysis system (Image-Pro
Plus; Media Cybernetics). Two investigators blinded to the study
protocol measured the infarct sizes with a computerized image
analyzer. To compensate for the effect of brain edema, the corrected
infarct volume was calculated: Corrected infarct areaMeasured
infarct area{1[(Ipsilateral hemisphere areaContralateral hemi-
sphere area)/Contralateral hemisphere]}.15
Local Cerebral Blood Flow Measurement
Laser-Doppler flowmetry (Perimed; Probe 403, Sweden) was per-
formed to monitor local cerebral blood flow (LCBF) of ischemic
cortical area supplied by the MCA throughout the I/R process. The
animals were placed with the head immobilized in a stereotaxic
frame and the probe was placed in a burr hole over the parietal cortex
distal to the site of core ischemic damage. The LCBF was deter-
mined before ischemia, during ischemia, and then for 3 hours after
injection of drug at the reperfusion. Flow values shown were
expressed as percent of baseline.
Neurological Scores
To examine the effects of the nitrite (480 nmol) on the neurological
deficits of rats after cerebral I/R, behavioral tests were performed by
2 investigators blinded to the treatment status of the rats with
modified limb placing tests (MLPT) and Rotorod test.15,16 The
animals were monitored during the period of postoperative recovery
starting at 2 hours, or 1, 3, or 7 days after I/R (n6 per group).
Cyclic Guanosine Monophosphate Measurement in
Brain Tissue
Levels of cyclic guanosine monophosphate (cGMP) in the ipsilateral
hemisphere of ischemic brain with saline, nitrite (480 nmol), or
nitrite (480 nmol) treatment after stroke in rats were measured (n3
per group). The animals were killed at 1 day after I/R and the
ipsilateral hemisphere cortical tissue was rapidly dissected. Levels of
cGMP were measured using a commercially available low pH
Immunoassay kit (R&D Systems Inc) according to the manufactur-
er’s instruction. Values for cGMP were standardized by total protein
(picomolars per milligrams tissue).
Analysis of Superoxide and
Peroxynitrite Formation
Three hours after reperfusion, the rat brains were processed for the
analysis of oxidative and nitrative stress (n6 per group). The
oxidative fluorescent dye dihydroethidium (DHE; Sigma-Aldrich)
was used to evaluate in situ production of superoxide.17 Frozen
enzymatically intact brains were cut into 30-m-thick sections and
placed on a glass slide. The sections were simultaneously incubated
with DHE (10 mol/L) in phosphate-buffered saline for 30 minutes
at 37°C, in a humidified chamber that was shielded from light. We
also monitored peroxynitrite formation by detecting nitrosylated
tyrosine residues on proteins. We performed immunostaining with
anti-3-nitrotyrosine (3-NT) antibody (1:1000; Upstate Biotechnol-
ogy). Coronal sections cut through the striatum (3 sections per brain,
1 mm in width) were imaged in parallel. Superoxide or 3-NT–
positive cells were manually counted in the eight regions around the
striatum under 100 magnification using a laser scanning confocal
microscopy with a Bio-Rad MRC 1024 (argon and krypton).
Measurement of Lipid Peroxidation
Malondialdehyde (MDA) was estimated as an indicator of lipid
peroxidation (n3 per group). The brain tissues were homogenized
with sodium phosphate buffer (pH 7.4). The reagents (1.5 mL acetic
acid, 1.5 mL thiobarbituric acid, and 0.2 mL sodium dodecyl sulfate)
were added to 0.1 mL of processed tissue sample. The mixture was
then heated at 100°C for 60 minutes. The mixture was cooled with
tap water and 5 mL of n-butanol: pyridine (15:1) and 1 mL of
distilled water was added. After centrifugation at 4000 rpm for 10
minutes, the organic layer was withdrawn and absorbance was
measured at 532 nm using a spectrophotometer.
Statistical Analysis
All data in this study are expressed as meansstandard deviations.
Data were analyzed by 1-way analysis of variance (ANOVA)
followed by Tukey test (when appropriate) or Student t test if they
were normally distributed. In the case of LCBF measurement, values
of different time points were compared by 2-way repeated measures
ANOVA. Without normal distribution, we used the Mann–Whitney
U test. P0.05 was regarded as statistically significant.
Results
Nitrite Exerted Dose-Dependent Neuroprotective
Effects in Ischemic Brains
In the ischemia-control group, I/R produced a well-defined
infarct involving both the neocortex and the striatum (Figure
1A). We investigated the effects of nitrite (48 to 4800 nmol)
or nitrate (480 nmol) on cerebral infarct size after I/R (Figure
1B to 1E). The nitrite-treated (48 and 480 nmol) group
exhibited an infarct 33% and 77% smaller than that of
saline-treated group (Figure 1F, n12, P0.05, ANOVA and
Tukey’s test). The administration of 4800 nmol nitrite and
480 nmol nitrate failed to limit cerebral infarct volume.
Nitrite Treatment Enhanced Local Cerebral Blood
Flow Without Blood Pressure Changes
The experimental groups did not differ with respect to the
pre-ischemic, intra-ischemic, or postischemic rectal temper-
ature, arterial blood gases, and pH values. Mean arterial blood
pressure also showed no significant differences between
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saline-treated and nitrite-treated (480 nmol) animals until 60
minutes after drug administration (see Table I, available at
http://stroke.ahajournals.org). Dynamic changes in ipsilateral
LCBF measured by laser-Doppler flowmetry were measured
starting 30 minutes before induction of ischemia until 3 hours
after reperfusion. In all groups, MCA occlusion resulted in an
immediate reduction of LCBF to 10% of baseline. After
reperfusion, a short period of postischemic hyperemia was
followed by a decrease below normal values. The LCBF
significantly increased in the ischemic hemisphere in
intermediate-dose nitrite treatment (480 nmol; range, 15812%
to 10210%), but not in nitrate treatment (480 nmol; range,
14018% to 639%), immediately after drug administration at
the reperfusion (Figure 2A; n3, P0.05, ANOVA). The
increase in LCBF was independent of changes in arterial
pressure and blood gases.
Nitrite Treatment Promoted Functional Recovery
The reduction in infarct volume by nitrite (480 nmol) was
associated with a better performance on the MLPT and
Rotorod test. Both the nitrite-treated group and the ischemia-
control group exhibited equal deficits in neurological scale at
2 hours after I/R. The nitrite-treated group showed less neuro-
logical deficit and exhibited better recovery characteristics, with
significant difference from day 1 after I/R (Figure 2B, 2C; n6,
P0.01, t test). At day 7, the group of rats which had been
treated with nitrite scored 2 points on the MLPT and exhibited
a 25% better recovery on the rotarod test.
Neuroprotective Effects of Nitrite Are Dependent
on NO
Although the carboxy-PTIO alone did not aggravate the
infarct volume, pretreatment with carboxy-PTIO completely
abolished the protective effects of nitrite therapy (Figure 3E;
n12, ANOVA and Tukey’s test). In addition, we evaluated
the effect of nitrite (480 nmol) or nitrate (480 nmol) on the
levels of cGMP in ipsilateral cortex of rats with I/R injury.
Saline-treated rats after I/R exhibited a significantly higher
level of cortical cGMP compared with normal control rats.
Administration of nitrite significantly increased cGMP
(2.00.4 pmol/mg, P0.05) compared with the saline-
treated (1.40.3 pmol/mg) or nitrate-treated (1.40.3
pmol/mg) group in the ipsilateral hemisphere at 1 day after
I/R (Figure 3F; n3, P0.05, ANOVA and Tukey test).
Adequate Dose of Nitrite Reduced the Oxidative
Stress in the Ischemic Brain
In the normal rats, few evidence of DHE-induced EtBr
fluorescence or 3-NT immunoreactivity was observed in the
cortex and striatum. Superoxide-generating cells and 3-NT–
Figure 1. Nitrite-mediated protection against cerebral I/R injury. A to E, Representative photomicrographs of TTC staining 24 hours
after I/R show the effect of saline, nitrite, or nitrate on the infarct volume. F, Evaluation of corrected infarction volume demonstrates that
nitrite (48 and 480 nmol) has induced a reduction in infarction volumes as compared with the saline-treated or nitrate-treated groups.
Bars represent meanSD. *P0.05 vs the saline-treated I/R group (n12, ANOVA and Tukey test).
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positive cells were increased in the ischemic hemisphere
(19220, 10323 cells per section, respectively), whereas
only a few labeled cells were detected in the nonischemic
hemisphere (Figure 4). Data from image analysis indicated
decreases of superoxide (5118 cells per section) and 3-NT
production (4419 cells per section) in the 480 nmol nitrite-
treated group, compared with the ischemia-control group
(Figure 4; n6, P0.05, ANOVA and Tukey test). In
contrast, higher concentration of nitrite (4800 nmol) failed to
attenuate the superoxide production (16923 cells per sec-
tion), and rather increased the 3-NT formation (13812 cells
per section) in the ischemic brain. These histological results
were further supported by biochemical assay for MDA, a
lipid peroxidation product. Nitrite (480 nmol) significantly
decreased the levels of MDA (0.310.06 g/mg protein) as
compared with the saline-treated group (0.420.04 g/mg
protein) (Figure 4H; n3, P0.05, Mann–Whitney U test).
Discussion
The effective NO synthesis may be particularly important in
protection against I/R injury. The NO release from nitrite is
increased rapidly under conditions of acidosis or hypoxia.
This concept has led to studies testing nitrite as a direct NO
donor in experimental ischemia models, such as hypoxia-
induced pulmonary vasoconstriction,18 hemorrhagic stroke,19
hepatic and cardiac I/R injury,13 and renal I/R injury.20 Nitrite
exerted profound dose-dependent protective effects against
hepatic and myocardial I/R, although it did not provide
protection in renal I/R injury, suggesting a unique metabolism
of nitrite in each tissue.15,20 Cerebral ischemia also decreases
the extracellular pH and oxygen level in the brain. Therefore,
NO can be generated efficiently in the ischemic brain by
direct reduction of nitrite. In our experiments, nitrite treat-
ment conferred significant neuroprotection that was associ-
ated with a marked improvement in clinical recovery.
Figure 2. Effects of nitrite on LCBF and functional deficits. A, The laser Doppler flow values are presented as percent of combined
averaged baseline values. Baseline, ischemia, and reperfusion points are represented by B, I, and R, respectively. The values are com-
pared within the group at indicated time, and the LCBF data are shown as meansSD. Significant differences are denoted by *P0.05
(n3, ANOVA). Serial data from (B) MLPT and (C) rotarod test showed a clear effect of 480 nmol nitrite on the motor functions after I/R
injury. In the MLPT and rotarod test at 2 hours, and 1, 3, and 7 days after I/R, nitrite-treated group exhibited less pronounced initial
deficits, and recovered better than did the saline-treated I/R group. Bars represent meanSD. *P0.05 vs the saline-treated I/R group
(n6, t test).
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The vascular mechanism is responsible for the neuroprotec-
tive effect of nitrite. Low and nontoxic doses of sodium nitrite
were able to increase LCBF rapidly in the ischemic brain
without concomitant hypotension. These results support the
concept that the biological activity of NO can exist in the local
circulation around the ischemic brain. To further clarify a
mechanism involving the hypoxic reduction of nitrite to NO, we
preceded nitrite with carboxy-PTIO. The carboxy-PTIO has
been reported to react with NO to generate NO2 and PTI
derivative in a stoichiometric manner.21 In this study, the
carboxy-PTIO completely inhibited protective effects of nitrite
in the ischemic brain, suggesting the NO-dependent action of
nitrite. In addition, our data that carboxy-PTIO alone did not
affect the infarct size suggested that the carboxy-PTIO might
preferentially quench the biological action of excess NO without
affecting NOS activity or endogenous nitrite. Because the
formation of carboxy-PTI and/or NO2 may complicate the
interpretation of data, the possibility that its reaction products
contribute to the antagonism should be also considered.
The indirect way of demonstrating the NO-dependent mech-
anism of nitrite is to measure the degree to which NO receptors
in the tissue are active. NO receptors possess intrinsic guanylyl
cyclase activity, and so when they are stimulated, cGMP
accumulates in the cells.22 Our data that nitrite treatment in-
creased the cGMP level in the cerebral I/R supported that nitrite
effect was mediated via a NO/guanylyl cyclase/cGMP pathway.
However, S-nitrosothiols and N-nitrosamines formed via reac-
tions of nitrite with deoxyhemoglobin and possibly tissue heme
proteins may have critical effects on protection against I/R
injury.23 To further demonstrate the pharmacological profiles of
Figure 3. Neuroprotection mediated by nitrite-derived NO. A to D, Representative photomicrographs of TTC staining 24 hours after I/R
showed the effect of the carboxy-PTIO on the infarct volume. E, Evaluation of corrected infarction volume demonstrated that carboxy-
PTIO completely inhibited the neuroprotective effects of nitrite (n12, ANOVA and Tukey test). F, Nitrite treatment increases the cGMP
level in the ipsilateral cortex after I/R. *P0.05 vs the saline-treated I/R group (n3, ANOVA and Tukey test).
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nitrite in the cerebral I/R paradigm, the new analyzing tech-
niques need to be developed to discriminate between the various
NO-related compounds.
Another important finding in this study is that the nitrite
effect is dose-dependent. NO is highly reactive with other
free radicals, and the reaction between NO and superoxide
can promote protection by reducing superoxide toxicity.3,4
However, NO produced in massive outbursts may form a
stronger oxidant peroxynitrite with resultant protein nitration,
DNA damage, and energy failure.24 It is now well appreciated
that very high, nonphysiological levels of NO actually pro-
mote cellular necrosis and apoptosis, whereas the demon-
strated protective effects of NO typically involve nanomolar
or low micromolar concentrations of NO.8 In our study, the
480 nmol nitrite could confer the antioxidant effects in the
ischemic brain, whereas the detrimental effects of high dose
of nitrite after I/R were most likely secondary to nitrite-
mediated generation of superoxide or peroxynitrite. There-
fore, the strategies simply increasing NO in ischemic cortex
may even exacerbate the I/R injury.
Targeting neurovascular protection by structurally suitable
NO donor in the ischemic brain might be effective candidates
for the treatment of acute stroke. Our observations not only
expand our understanding of the physiological roles of NO in
the brain but also offer novel treatment strategies targeting
the efficient NO donation.
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